Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke: An enzymatic test for predicting outcome?

Stroke

Volumn 27, Issue 11, 1996, Pages 2064-2068

  Butterworth, R J ^a   Wassif, W S ^a   Sherwood, R A ^a   Gerges, A ^a   Poyser, K H ^a   Garthwaite, J ^b   Peters, T J ^a   Bath, P M W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

GABA; neuron specific enolase; serum carnosinase; stroke outcome; stroke, acute

Indexed keywords

AMINOACYLHISTIDINE DIPEPTIDASE; BRAIN PROTEIN; ENOLASE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN ISCHEMIA; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; PRIORITY JOURNAL; PROGNOSIS; STROKE;

EID: 0029852673     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.11.2064     Document Type: Article

References (21)

1. Hay E, Royds JA, Davies-Jones GAB, Lewtas NA, Timberley WR, Taylor CB. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry. 1984;47:724-729.
2. Persson L, Hårdemark H-G, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 and neurone specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
3. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest. 1991; 21:497-500.
4. Schaarschmidt H, Prange HW, Reiber H. Neurone specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;25:558-565.
5. Wassif WS, Sherwood RA, Amir A, Idowu B, Summers B, Leigh N, Peters TJ. Serum carnosinase activities in central nervous system disorders. Clin Chim Acta. 1994;225:57-64.
6. Bath PMW, Butterworth RJ, Soo J, Kerr J. The King's College Hospital Acute Stroke Unit. J R Coll Physicians Lond. 1996;30:13-17.
7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
8. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200-215.
9. Lindley RI, Waddell F, Livingstone M, Sandercock P, Dennis MS, Slattery J, Smith B, Warlow C. Can simple questions assess outcome after stroke? Cerebrovasc Dis. 1994;4:314-324.
10. Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W. Clinical biochemistry of neurone specific enolase. Clin Chim Acta. 1989; 183:13-32.
11. Wassif WS, Preedy VR, Summers P, Duane P, Leigh N, Peters TJ. The relationship between muscle fibre atrophy factor, plasma carnosinase activities and muscle RNA and protein composition in chronic alcoholic myopathy. Alcohol Alcohol. 1993;28:325-331.
12. Siegal S, Castellan NJ. Non-parametric Statistics for the Behavioural Sciences. 2nd ed. London, England: McGraw-Hill Book Co; 1988.
13. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
14. Marangos PJ, Schmechal DE. Neurone specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269-295.
15. Hatfield RH, McKernan RM. CSF neurone specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res. 1992;577:249-252.
16. Steinberg R, Gueniau C, Scarna H, Keller A, Worcel M, Pujol JF. Experimental brain ischemia: neurone specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem. 1984;43:19-24.
17. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;1:480-484.
18. Jackson MC, Kucera CM, Lenney JF. Purification and properties of human serum carnosinase. Clin Chim Acta. 1991;196:193-206.
19. Jackson MC, Scollard DM. Mack RJ, Lenney JF. Localization of a novel pathway for the liberation of GABA in the human CNS. Brain Res Bull. 1994;33:379-385.
20. Kish SJ, Perry TL, Hansen S. Regional distribution of homocarnosine, homocarnosine-carnosine synthetase and homocaraosinase in human brain. J Neurochem. 1979;32:1629-1636.
21. Butterworth RJ, Wassif WS, Gerges A, Sherwood RA, Peters TJ, Bath PMW. Serum carnosinase activity is reduced in acute stroke. Cerebrovasc Dis. 1995;5:246, Abstract.